Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | DGKA | P23743 | 1/20 | 0.55 |
| ▸ | PAM | P19021 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | PRKCA | P17252 | 1/20 | 0.46 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.46 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.46 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.46 |
| ▸ | NAAA | Q02083 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4627242 | 1.00 | LMNA (0.56) | LMNAMAPTDGKAPAMALDH1A1 | |
| SCHEMBL27764263 | 1.00 | LMNA (0.56) | LMNAMAPTDGKAPAMALDH1A1 | |
| SCHEMBL9666107 | 1.00 | LMNA (0.56) | LMNAMAPTDGKAPAMALDH1A1 | |
| SCHEMBL29043323 | 1.00 | LMNA (0.56) | LMNAMAPTDGKAPAMALDH1A1 | |
| SCHEMBL4627513 | 1.00 | LMNA (0.56) | LMNAMAPTDGKAPAMALDH1A1 | |
| SCHEMBL898141 | 1.00 | LMNA (0.56) | LMNAMAPTDGKAPAMALDH1A1 | |
| SCHEMBL17204169 | 1.00 | LMNA (0.56) | LMNAMAPTDGKAPAMALDH1A1 | |
| SCHEMBL15689282 | 1.00 | LMNA (0.56) | LMNAMAPTDGKAPAMALDH1A1 | |
| SCHEMBL15649885 | 1.00 | LMNA (0.56) | LMNAMAPTDGKAPAMALDH1A1 | |
| SCHEMBL4627239 | 1.00 | LMNA (0.56) | LMNAMAPTDGKAPAMALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7714154-B2 | Preparation of amino acid-fatty acid anhydrides | NORTHERN INNOVATIONS AND FORMULATIONS CORP. (CA) | 2010-05-11 | — | — | US | disclosed |
| US-7511162-B2 | Preparation of amino acid-fatty acid anhydrides | MULTI FORMULATIONS LTD. (CA) | 2009-03-31 | — | — | US | disclosed |
| WO-2008138090-A1 | PREPARATION OF AMINO ACID-FATTY ACID ANHYDRIDES | MULTI FORMULATIONS LTD. (CA) | 2008-11-20 | — | — | WO | disclosed |
| US-20080281113-A1 | Preparation of amino acid-fatty acid anhydrides | MULTI FORMULATIONS LTD (CA) | 2008-11-13 | — | — | US | disclosed |
| US-20080200725-A1 | Enhanced bioavailability; reacting fatty acid and amino acid using thionyl halide | 2462096 ONTARIO LIMITED (CA) | 2008-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080281113-A1 | Preparation of amino acid-fatty acid anhydrides | FABP2, FABP4, FABP1 | LMNA 3622/4885MAPT 3477/4885DGKA 1789/4885 |
| US-20080200725-A1 | Enhanced bioavailability; reacting fatty acid and amino acid using thionyl halide | FABP2, FABP1, FABP4 | LMNA 3951/4885MAPT 3380/4885DGKA 2419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.